#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kidney transplant rejection Barth syndrome Philadelphia positive acute lymphocytic leukaemia Endometrial adenocarcinoma Immune thrombocytopenia Insulinoma Chronic myeloid leukaemia (in remission) Human papilloma virus immunisation Epilepsy with myoclonic-atonic seizures Glomerulonephritis minimal lesion Idiopathic pulmonary fibrosis Non-Hodgkin's lymphoma refractory Hereditary motor and sensory neuropathy Extra-osseous Ewing's sarcoma Mantle cell lymphoma stage IV More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Life with Disease Cholangitis sclerosing – Treatment Castleman’s disease – Diagnostics Myxofibrosarcoma Osteosarcoma metastatic – Basic Information Cholangitis sclerosing – Basic Information Mucopolysaccharidosis I – Treatment Mantle cell lymphoma stage II – Treatment Mucous membrane pemphigoid – Life with Disease Cholangitis sclerosing More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lovo-B Formoterol Fumarate Etamsylate CEFTAROLINE FOSAMIL IDP-121 Colecalciferol Plasma Linagliptin S227928 SC0062 Munc-T3 Zetomipzomib VOROLANIB Relacorilant Levonorgestrel Sodium Glycerophosphate Tuparstobart Tofacitinib INCB123667 Ale.c04 More therapies…

    Learn about Your Condition

    Ectopic pregnancy Decreased appetite ROHHAD syndrome Myasthenia gravis Postpartum haemorrhage Head and neck cancer Angiosarcoma recurrent Type 2 diabetes mellitus Myxoid liposarcoma Oedema peripheral Haemodialysis Head and neck cancer stage IV Mitral valve disease Breast cancer female Metabolic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Granulomatosis with polyangiitis

  • Study of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    • Systemic scleroderma
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Blinatumomab
    Germany

  • Study on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Obinutuzumab
    France

  • Rituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone
    • Rituximab
    France

  • Study of Empagliflozin, Losartan Potassium and Hydrochlorothiazide to Prevent Kidney Stones in Patients with Paraffin Oil Induced Granulomatous Disease

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Hydrochlorothiazide
    • Losartan Potassium
    • Empagliflozin
    Denmark

  • Study on Rituximab, Tocilizumab, and Tofacitinib for Patients with Granulomatosis with Polyangiitis Not Responding to Standard Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Azathioprine
    • Methotrexate
    • Mycophenolate Mofetil
    France

  • Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    • Microscopic polyangiitis
    Investigated Drugs:
    • Iptacopan
    Austria Belgium Czechia Denmark France Germany +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!